Chicago Dismisses Depomed From Opioid Lawsuit, Renames Other Defendants
In January, Depomed bought Nucynta from Janssen Pharmaceuticals Inc., which is a defendant in the city’s 2014 lawsuit. Depomed was named as a defendant along with six other opioid makers in an amended lawsuit filed Nov. 5, 2015, in the U.S. District Court for the Northern District of Ohio.
According to the...
To view the full article, register now.